Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study

We assessed the efficacy and safety profile of a docetaxel (Taxotere; Sanofi-Aventis, France), fluorouracil (FU), and leucovorin (LV) combination (TFL), as first-line chemotherapy in patients with advanced gastric cancer. Fifty-eight patients with advanced gastric cancer were entered in this phase I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2006-02, Vol.9 (1), p.26-31
Hauptverfasser:	Papakostas, Pavlos, Tsavdaridis, Dimitrios, Kosmidis, Paris, Kalofonos, Haralabos P, Sakantamis, Athanassios, Janinis, Dimitrios, Skarlos, Dimosthenis, Bafaloukos, Dimitrios, Bamias, Aristotelis, Xiros, Nikos, Fountzilas, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Female Fluorouracil - administration & dosage Gastric cancer Humans Leucovorin - administration & dosage Male Maximum Tolerated Dose Middle Aged Oncology Stomach Neoplasms - drug therapy Stomach Neoplasms - secondary Survival Rate Taxoids - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!